Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

OBJECTIVE: To find the combination of candidate biomarkers and cognitive endpoints to maximize statistical power and minimize cost of clinical trials of healthy elders at risk for cognitive decline due to Alzheimer's disease. METHODS: Four-hundred and twelve cognitively normal participants were...

Descripción completa

Detalles Bibliográficos
Autores principales: Insel, Philip S, Mattsson, Niklas, Mackin, R Scott, Kornak, John, Nosheny, Rachel, Tosun-Turgut, Duygu, Donohue, Michael C, Aisen, Paul S, Weiner, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435707/
https://www.ncbi.nlm.nih.gov/pubmed/26000325
http://dx.doi.org/10.1002/acn3.192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435707/
https://www.ncbi.nlm.nih.gov/pubmed/26000325
http://dx.doi.org/10.1002/acn3.192

Ejemplares similares